Marketing-authorisation holder · Germany
B. Braun Melsungen Ag
146 medicines in 6 countries, as authorisation holder, manufacturer and marketer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Germany
146 medicines in 6 countries, as authorisation holder, manufacturer and marketer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 146
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACETAMINOPHEN INJECTION500 mg / 50 ml · Solution | Paracetamol | Canada | Marketed | 2023 |
| ACETAMINOPHEN INJECTION100 mg / 10 ml · Solution | Paracetamol | Canada | Marketed | 2023 |
| ACETAMINOPHEN INJECTION1000 mg / 100 ml · Solution | Paracetamol | Canada | Marketed | 2024 |
| ACQUA PER PREPARAZIONI INIETTABILI B. BRAUNSolvente per uso parenterale | Acqua preparazioni iniettabili | Italy | Authorised | |
| AMIKACINA B. BRAUNSoluzione per infusione | Amikacin | Italy | Authorised | |
| AMINOPLASMAL B.BRAUN 10% E SOLUCION PARA PERFUSION0,4 g + 5 g + 8,9 g + 4,4 g + 4,7 g + 4,2 g + 8,56 g + 1,6 g + 6,2 g + 11,5 g + 3 g + 10,5 g + 12 g + 5,6 g + 7,2 g + 5,5 g + 2,3 g + 2.858 g + 0,36 g + 2.453 g + 0,508 g + 3.581 g · Solución para perfusión | Tyrosine, Isoleucine, Amino acids, Methionine, Phenylalanine, Threonine, Lysine, Tryptophan, Valine, Arginine, Histidine, Alanine, Glycine, Aspartic acid, Glutamic acid, Proline, Serine, Acetato sodio trihidrato, Hydroxide, Potassium, Magnesio cloruro hexahidrato, Disodio dodecahidrato | Spain | Marketed | 2005 |
| AMINOPLASMAL B.BRAUN 10% SOLUCION PARA PERFUSION5 g + 8,9 g + 5,74 g + 3,12 g + 4,4 g + 4,7 g + 4,2 g + 1,6 g + 6,2 g + 11,5 g + 3 g + 10,5 g + 12 g + 5,6 g + 7,2 g + 5,5 g + 2,3 g + 0,4 g · Solución para perfusión | Isoleucine, Amino acids, Lysine, Methionine, Phenylalanine, Threonine, Tryptophan, Valine, Arginine, Histidine, Alanine, Glycine, Aspartic acid, Glutamic acid, Proline, Serine, Tyrosine | Spain | Marketed | 2005 |
| AMINOPLASMAL B.BRAUN 15% SOLUCION PARA PERFUSION5,85 g + 11,40 g + 5,70 g + 5,40 g + 5,40 g + 8,93 g + 2,10 g + 7,20 g + 16,05 g + 5,25 g + 22,35 g + 19,20 g + 7,95 g + 16,20 g + 7,35 g + 3,00 g + 0,50 g + 0,50 g · Solución para perfusión | Isoleucine, Amino acids, Methionine, Phenylalanine, Threonine, Lysine, Tryptophan, Valine, Arginine, Histidine, Alanine, Glycine, Aspartic acid, Glutamic acid, Proline, Serine, Tyrosine, Acetylcysteine | Spain | Marketed | 2014 |
| AMINOPLASMAL B.BRAUN 5% SOLUCION PARA PERFUSION2,5 g + 2,87 g + 1,56 g + 2,2 g + 4,45 g + 2,35 g + 2,1 g + 0,8 g + 3,1 g + 5,75 g + 1,5 g + 5,25 g + 6 g + 2,8 g + 3,6 g + 2,75 g + 1,15 g + 0,4 g · Solución para perfusión | Isoleucine, Lysine, Methionine, Amino acids, Phenylalanine, Threonine, Tryptophan, Valine, Arginine, Histidine, Alanine, Glycine, Aspartic acid, Glutamic acid, Proline, Serine, Tyrosine | Spain | Marketed | 2005 |
| AMINOPLASMAL PAED 10% SOLUCION PARA PERFUSION5,10 mg + 7,60 mg + 2,00 mg + 3,10 mg + 5,10 mg + 4,00 mg + 9,10 mg + 4,60 mg + 15,90 mg + 2,00 mg + 9,30 mg + 6,10 mg + 2,00 mg + 1,30 mg + 0,300 mg + 9,88 mg + 6,10 mg + 6,60 mg + 0,700 mg · Solución para perfusión | Isoleucine, Amino acids, Methionine, Phenylalanine, Threonine, Tryptophan, Arginine, Histidine, Alanine, Glycine, Glutamic acid, Proline, Serine, Acetiltirosina, Taurine, Lysine, Valine, Aspartic acid, Acetylcysteine | Spain | Marketed | 2014 |
| AMIPEDSoluzione per infusione | Amino acids | Italy | Authorised | |
| AMIXALSoluzione per infusione | Amino acids, Elettroliti | Italy | Authorised | |
| BASALFLEXSoluzione per infusione | Amino acids, Calcium, Glucose, Elettroliti | Italy | Authorised | |
| BRAUNOLSoluzione cutanea | Povidone-iodine | Italy | Authorised | |
| CALCIO GLUCONATO B. BRAUNSoluzione iniettabile | Calcium gluconate | Italy | Authorised | |
| CLOROTEKAL10 mg / ml · Solution | Chloroprocaine | Canada | Marketed | 2025 |
| DECELEXSoluzione iniettabile | Chloroprocaine | Italy | Authorised | |
| DEXMEDETOMIDINA B. BRAUN 100 MICROGRAMOS/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG118 µg · Concentrado para solución para perfusión | Dexmedetomidine | Spain | Marketed | 2020 |
| DEXMEDETOMIDINA B. BRAUN 4 MICROGRAMOS/ML SOLUCION PARA PERFUSION4,73 microgramos/ml · Solución para perfusión | Dexmedetomidine | Spain | Marketed | 2024 |
| DEXMEDETOMIDINA B. BRAUN 8 MICROGRAMOS/ ML SOLUCION PARA PERFUSION9,46 microgramos/ml · Solución para perfusión | Dexmedetomidine | Spain | Marketed | 2024 |
| ENVITAVITPolvere per soluzione per infusione endovenosa | Vitamin b2 | Italy | Authorised | |
| ETOMIDATO -LIPURO 2 mg/ml EMULSION INYECTABLE20 mg · Emulsion inyectable | Etomidate | Spain | Marketed | 2001 |
| FLUCONAZOL B. BRAUN 2 mg/ml SOLUCION PARA PERFUSION EFG2 mg · Solución para perfusión | Fluconazole | Spain | Marketed | 2009 |
| FLUCONAZOLO B. BRAUNSoluzione per infusione | Fluconazole | Italy | Authorised | |
| FLUMAZENIL B. BRAUNSoluzione iniettabile | Flumazenil | Italy | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 50 | 39 | 11 | CompaniesAll medicines |
| Romania | 44 | 0 | 44 | CompaniesAll medicines |
| Italy | 39 | 39 | 0 | CompaniesAll medicines |
| Saudi Arabia | 5 | 5 | 0 | CompaniesAll medicines |
| Canada | 4 | 4 | 0 | CompaniesAll medicines |
| Croatia | 4 | 4 | 0 | CompaniesAll medicines |
Also in the registers of Brazil, France, Serbia, Singapore, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.